Literature DB >> 32704135

Long-acting antiretroviral therapy.

Vicente Soriano1,2, Pablo Barreiro3, Carmen de Mendoza4.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32704135     DOI： 10.1038/s41563-020-0731-7

Source DB:  PubMed          Journal:  Nat Mater        ISSN： 1476-1122            Impact factor:   43.841


× No keyword cloud information.
  8 in total

Review 1.  Pre-Exposure Prophylaxis for viral infections other than HIV.

Authors:  Vicente Soriano; Ana Treviño; Carmen de Mendoza; Víctor Moreno-Torres; Ilduara Pintos; Pablo Barreiro; Octavio Corral
Journal:  Infez Med       Date:  2022-09-01

2.  Virus-Mimicking Polymer Nanoparticles Targeting CD169+ Macrophages as Long-Acting Nanocarriers for Combination Antiretrovirals.

Authors:  Behnaz Eshaghi; Josiane Fofana; Sarah B Nodder; Suryaram Gummuluru; Björn M Reinhard
Journal:  ACS Appl Mater Interfaces       Date:  2022-01-07       Impact factor: 10.383

3.  Oral antivirals for the prevention and treatment of SARS-CoV-2 infection.

Authors:  Vicente Soriano; Carmen de-Mendoza; Benson Edagwa; Ana Treviño; Pablo Barreiro; José V Fernandez-Montero; Howard E Gendelman
Journal:  AIDS Rev       Date:  2022-03-01       Impact factor: 2.381

4.  Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation.

Authors:  Suyash Deodhar; Brady Sillman; Aditya N Bade; Sean N Avedissian; Anthony T Podany; JoEllyn M McMillan; Nagsen Gautam; Brandon Hanson; Bhagya L Dyavar Shetty; Adam Szlachetka; Morgan Johnston; Michellie Thurman; Daniel J Munt; Alekha K Dash; Milica Markovic; Arik Dahan; Yazen Alnouti; Alborz Yazdi; Bhavesh D Kevadiya; Siddappa N Byrareddy; Samuel M Cohen; Benson Edagwa; Howard E Gendelman
Journal:  Nat Commun       Date:  2022-06-09       Impact factor: 17.694

Review 5.  Long-acting antiretrovirals: a new era for the management and prevention of HIV infection.

Authors:  Paul Thoueille; Eva Choong; Matthias Cavassini; Thierry Buclin; Laurent A Decosterd
Journal:  J Antimicrob Chemother       Date:  2022-02-02       Impact factor: 5.790

6.  The co-occurrence of the SAVA syndemic, depression and anxiety as barriers to antiretroviral therapy adherence among sub-Saharan Africa population groups: A scoping review protocol.

Authors:  Anton Delport; Hanani Tabana; Lucia Knight; Edwin Wouters
Journal:  PLoS One       Date:  2022-09-20       Impact factor: 3.752

Review 7.  The Yin and the Yang of Treatment for Chronic Hepatitis B-When to Start, When to Stop Nucleos(t)ide Analogue Therapy.

Authors:  Samuel Hall; Jessica Howell; Kumar Visvanathan; Alexander Thompson
Journal:  Viruses       Date:  2020-08-25       Impact factor: 5.048

Review 8.  Genome Editing Technologies as Cellular Defense Against Viral Pathogens.

Authors:  Yingzi Zhang; Mo Li
Journal:  Front Cell Dev Biol       Date:  2021-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.